2023 Compensation Trends at the World’s Largest Pharma and Biotech Companies” ###

Median Employee Pay Varied Widely:
Gilead Sciences led the pack with a median employee pay of $205,866, while Teva Pharmaceuticals had the lowest median pay at $64,562 among major employers in the biopharma sector2 3.

CEO-to-Worker Pay Gaps: Significant disparities were evident in 2023, with some companies reporting high ratios. For example, Teva Pharmaceuticals had a 398:1 CEO-to-worker pay ratio, while Gilead Sciences had a relatively smaller gap of 110:
13.

High Median Pay at Smaller Biotechs:
Smaller biotech companies like Prothena and Cytokinetics offered the highest median pay, exceeding $400,000, reflecting the concentration of highly specialized roles in these firms6.

Pharmaceutical Scientists’ Pay Growth:
Pharmaceutical scientists in the U.S. saw their average salaries grow to $190,100 in 2023, a 6.7% increase from 2022. However, gender pay disparities persisted, with male scientists earning 22% more than their female counterparts5.

Notable Companies by Median Pay:

Amgen:
$166,322.

Regeneron Pharmaceuticals:
$165,843.

Eli Lilly:
$157,9373.

Global Trends:
Companies like Pfizer and Johnson & Johnson, despite large revenues, offered median employee salaries of $74,008 and $84,000, respectively, indicating broader pay disparities within the industry3 4.

Industry-Wide Median Pay:
Across all analyzed companies, the typical biopharma worker earned $199,048 in 2023, highlighting the industry's overall lucrative compensation trends despite significant variation between companies9.